Evidence map›Paper›PMID 35378876›Full record

ArticleInternational journal of women's health2022

Menstrual Symptoms After COVID-19 Vaccine: A Cross-Sectional Investigation in the MENA Region.

Nadia Muhaidat, Mohammad A Alshrouf, Muayad I Azzam, Abdulrahman M Karam, Majed W Al-Nazer, Abdallah Al-Ani

Open access · goldAbstract read
In one paragraph

Article in International journal of women's health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Menstrual Cycle Disturbances after COVID-19 Vaccination: A Cross-Sectional Study.International journal of fertility & sterility · 2024
    Article
  17. Article
  18. Abnormal uterine bleeding diagnoses and care following COVID-19 vaccination.American journal of obstetrics and gynecology · 2024
    Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nadia MuhaidatDepartment of Obstetrics & Gynaecology, Jordan University Hospital, Amman, Jordan.ORCID 0000-0002-3495-799X
Mohammad A AlshroufThe School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0000-0003-3806-2859
Muayad I AzzamThe School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0000-0002-2046-8343
Abdulrahman M KaramThe School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0000-0001-9182-2111
Majed W Al-NazerThe School of Medicine, The University of Jordan, Amman, Jordan.ORCID 0000-0002-6794-0860
Abdallah Al-AniKing Hussein Cancer Center, Amman, Jordan.ORCID 0000-0002-3517-3601
University of Jordan · JOJordan Hospital · JOKing Hussein Cancer Center · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Since the emergence of COVID-19 vaccinations, many women around the world are reporting abnormalities in their menstrual periods post-vaccination. The aim of this study is to investigate the prevalence and impact of menstrual abnormalities after the COVID-19 vaccine among females residing within the Middle East and North Africa (MENA). Methods: The study utilized a cross-sectional online self-administered survey from July 2021 to August 2021 targeting females living in the MENA region above the age of menarche who had received vaccine and were not pregnant or lactating, and do not have a history of primary ovarian insufficiency, hypothalamic menopause, or have undergone a hysterectomy. The survey was distributed regionally via social media. Results: A total of 2269 females were included in our study, with a mean age of 34.3 ± 8.5 years. About 66.3% of participants reported menstrual symptoms post-vaccination, of which 46.7% experienced them after their first dose. However, in 93.6% of participants, the symptoms resolved within 2 months. Vaccine type did not significantly influence the incidence of abnormalities (p > 0.05). Participants who had confirmed previous COVID-19 infection had a very similar percentage of menstrual abnormalities compared to people who did not have COVID-19 infection or symptoms suspected of COVID-19 infection and did not test (67.5%, 66.8%, respectively); nevertheless, those who had experienced the COVID-19 vaccine general side effects had significantly more abnormalities (p < 0.001). Compared to their pandemic status, females reported significantly more abnormalities post-vaccination. Conclusion: The study showed a possible link between the COVID-19 vaccine and menstrual abnormalities that have impacted their quality of life.

Indexed as

COVID-19MENAmenstrual abnormalitiesmenstrual cyclevaccine

Identifiers

PMID35378876
PMCPMC8976114
OpenAlexW4220826837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.